OrganiGram Holdings focuses on producing indoor-growth cannabis for patients and adult recreational consumers and developing overseas business partnerships.
Its brand portfolio includes Edison Reserve, Edison Cannabis Co, ANKR Organics, and Trailblazer.
Sales and EPS are expected to grow 64.1% and 320.0%, leading to a bullish reading. OGI stock is up 77.4% in the last month. But shares are still trading at 11.2 times price-to-earnings.
OGI has outperformed the S&P 500 by 185.1% and its sector by 198.2% in the past five years.
Based in Atlantic Canada OrganiGram sells medical cannabis both online and via phone to individuals and physicians. The company operates five healing centers for post-traumatic stress disorder treatment, chronic pain, trauma therapy, and medical cannabis as an alternative medicine. The company is effectively run and is located close to it's consumer market. With Marijuana stocks beaten up so bad in the past year, it's hard to see how this investment doesn't double or triple within the next few years.
No comments:
Post a Comment